Jasek-Gajda, E., Jurkowska, H., Jasińska, M., Litwin, J. A., & Lis, G. J. (2019). Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells. Apoptosis.

Jasek-Gajda, Ewa, Halina Jurkowska, Małgorzata Jasińska, Jan A. Litwin, och Grzegorz J. Lis. "Combination of ERK2 Inhibitor VX-11e and Voreloxin Synergistically Enhances Anti-proliferative and Pro-apoptotic Effects in Leukemia Cells." Apoptosis 2019.

Jasek-Gajda, Ewa, et al. "Combination of ERK2 Inhibitor VX-11e and Voreloxin Synergistically Enhances Anti-proliferative and Pro-apoptotic Effects in Leukemia Cells." Apoptosis 2019.